Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Venous Thrombosis

  Free Subscription


2 Chest
1 PLoS One
2 Thromb Haemost
4 Thromb Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. LANG IM
    Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Pulmonary Endarterectomy First!
    Chest. 2021;160:1599-1601.

    Initial Anticoagulant Treatment of Pulmonary Embolism: How Can We Better Predict Bleeding in the Early Days Rather Than the Early Months?
    Chest. 2021;160:1596-1598.

    PLoS One

  3. PEDERSEN S, Kristensen AF, Falkmer U, Christiansen G, et al
    Increased activity of procoagulant factors in patients with small cell lung cancer.
    PLoS One. 2021;16:e0253613.
    PubMed         Abstract available

    Thromb Haemost

  4. ZHOU C, Yi Q, Ge H, Wei H, et al
    Validation of risk assessment models predicting venous thromboembolism in inpatients with AECOPD: a multicenter cohort study.
    Thromb Haemost. 2021 Nov 10. doi: 10.1055/a-1693-0063.
    PubMed         Abstract available

  5. KHAN F, Rahman A, Tritschler T, Carrier M, et al
    Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis.
    Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728.
    PubMed         Abstract available

    Thromb Res

  6. GUPTA A, Chegondi M, Billa RD, Bloxham J, et al
    Validation of risk assessment models for venous thromboembolism and bleeding in critically ill adolescents.
    Thromb Res. 2021;208:106-111.
    PubMed         Abstract available

  7. NAYAK AL, Zahrai A, Mallick R, Wang TF, et al
    Efficacy of primary prevention of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: A post- hoc analysis of the AVERT trial.
    Thromb Res. 2021;208:79-82.
    PubMed         Abstract available

  8. HILL H, Robinson M, Lu L, Slaughter D, et al
    Venous thromboembolism incidence and risk factors in non-small cell lung cancer patients receiving first-line systemic therapy.
    Thromb Res. 2021;208:71-78.
    PubMed         Abstract available

  9. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2021 Nov 3. pii: S0049-3848(21)00492.

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.